Therefore, we aimed to collectively evaluate 18F‐FP‐CIT PET/123I‐FP‐CIT SPECT imaging findings of dopamine transporters in patients with PD, identify patterns of abnormalities, and propose evidence that can influence clinical decision‐making with respect to the diagnosis of PD. This evidence concerns the gene SLC6A3 and Parkinson disease.